Therapeutic vulnerabilities and resistance mechanisms in KRAS mutant lung adenocarcinoma

Información

Fecha: 16/10/2026
Hora 15:00
Lugar: Auditorio CNIO
Conferenciante Ana María Fernández
Procedencia Experimental Oncology Group, Tumour Biology Programme, CNIO
Supervised by Mariano Barbacid and Monica Musteanu, Experimental Oncology Group, Tumour Biology Programme, CNIO
Entrada libre hasta completar aforo